US Stock MarketDetailed Quotes

LCTX Lineage Cell Therapeutics

Watchlist
  • 0.831
  • -0.021-2.45%
Close Oct 31 16:00 ET
  • 0.877
  • +0.046+5.50%
Post 19:26 ET
156.98MMarket Cap-6394P/E (TTM)

Lineage Cell Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Lineage Cell Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 7.561M--
--2024/Q3-- / 886.570K--
Aug 8, 20242024/Q21.408M / 786.000K--
May 9, 20242024/Q11.444M / 1.360M--
Mar 7, 20242023/Q42.118M / 2.844M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 7.561M--
--2024/Q3-- / 886.570K--
Aug 8, 20242024/Q21.408M / 786.000K--
May 9, 20242024/Q11.444M / 1.360M--
Mar 7, 20242023/Q42.118M / 2.844M--

Unlock Free Earnings Estimates

Lineage Cell Therapeutics Earnings Reports

  • Lineage Cell Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 8 16:21 ET

  • Lineage Cell Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 9 17:03 ET

  • Lineage Cell Therapeutics | 10-K: FY2023 Annual Report

    Mar 7 22:16 ET

  • Lineage Cell Therapeutics | 10-Q: Q3 2023 Earnings Report

    Nov 9, 2023 16:15 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 31, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data